123 related articles for article (PubMed ID: 38173189)
1. Deregulation of miR-1245b-5p and miR-92a-3p and their potential target gene, GATA3, in epithelial-mesenchymal transition pathway in breast cancer.
Yadollahi Farsani M; Amini Farsani Z; Teimuri S; Kolahdouzan M; Eshraghi Samani R; Teimori H
Cancer Rep (Hoboken); 2024 Feb; 7(2):e1955. PubMed ID: 38173189
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-455-3p mediates GATA3 tumor suppression in mammary epithelial cells by inhibiting TGF-β signaling.
Zeng Y; Gao T; Huang W; Yang Y; Qiu R; Hou Y; Yu W; Leng S; Feng D; Liu W; Teng X; Yu H; Wang Y
J Biol Chem; 2019 Oct; 294(43):15808-15825. PubMed ID: 31492753
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-138-5p inhibits cell migration, invasion and EMT in breast cancer by directly targeting RHBDD1.
Zhao C; Ling X; Li X; Hou X; Zhao D
Breast Cancer; 2019 Nov; 26(6):817-825. PubMed ID: 31243644
[TBL] [Abstract][Full Text] [Related]
4. The Role of miRNAs 340-5p, 92a-3p, and 381-3p in Patients with Endometriosis: A Plasma and Mesenchymal Stem-Like Cell Study.
Bahramy A; Zafari N; Izadi P; Soleymani F; Kavousi S; Noruzinia M
Biomed Res Int; 2021; 2021():5298006. PubMed ID: 34631883
[TBL] [Abstract][Full Text] [Related]
5. Identification of potential microRNA diagnostic panels and uncovering regulatory mechanisms in breast cancer pathogenesis.
Sharifi Z; Talkhabi M; Taleahmad S
Sci Rep; 2022 Nov; 12(1):20135. PubMed ID: 36418345
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA miR-92a-3p regulates breast cancer cell proliferation and metastasis via regulating B-cell translocation gene 2 (BTG2).
Jinghua H; Qinghua Z; Chenchen C; Lili C; Xiao X; Yunfei W; Zhengzhe A; Changxiu L; Hui H
Bioengineered; 2021 Dec; 12(1):2033-2044. PubMed ID: 34082648
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance and immune characteristics analysis of miR-221-3p and its key target genes related to epithelial-mesenchymal transition in breast cancer.
Fang Y; Zhang Q; Chen Z; Guo C; Wu J
Aging (Albany NY); 2024 Jan; 16(1):322-347. PubMed ID: 38189813
[TBL] [Abstract][Full Text] [Related]
8. CAFs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial-mesenchymal transition in colorectal cancer.
Hu JL; Wang W; Lan XL; Zeng ZC; Liang YS; Yan YR; Song FY; Wang FF; Zhu XH; Liao WJ; Liao WT; Ding YQ; Liang L
Mol Cancer; 2019 May; 18(1):91. PubMed ID: 31064356
[TBL] [Abstract][Full Text] [Related]
9. MiR-191-5p inhibits KLF6 to promote epithelial-mesenchymal transition in breast cancer.
Pan L; Liu W; Zhao H; Chen B; Yue X
Technol Health Care; 2023; 31(6):2251-2265. PubMed ID: 37545272
[TBL] [Abstract][Full Text] [Related]
10. LncRNA AATBC indicates development and facilitates cell growth and metastasis of cervical cancer as a sponge of miR-1245b-5p.
Liu YQ; Liu C; Bai Y; Gao J
Kaohsiung J Med Sci; 2023 Feb; 39(2):115-123. PubMed ID: 36420764
[TBL] [Abstract][Full Text] [Related]
11. Aberrant expression of a five-microRNA signature in breast carcinoma as a promising biomarker for diagnosis.
Bitaraf A; Babashah S; Garshasbi M
J Clin Lab Anal; 2020 Feb; 34(2):e23063. PubMed ID: 31595567
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
Lu C; Shan Z; Hong J; Yang L
Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
[TBL] [Abstract][Full Text] [Related]
13. Clinical and
Ilkhani K; Delgir S; Safi A; Seif F; Samei A; Bastami M; Alivand MR
Anticancer Agents Med Chem; 2021; 21(7):927-935. PubMed ID: 32972352
[TBL] [Abstract][Full Text] [Related]
14. miR-205-5p Downregulation and
Kalinkova L; Nikolaieva N; Smolkova B; Ciernikova S; Kajo K; Bella V; Kajabova VH; Kosnacova H; Minarik G; Fridrichova I
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008529
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia-inhibited miR-338-3p suppresses breast cancer progression by directly targeting ZEB2.
He J; Wang J; Li S; Li T; Chen K; Zhang S
Cancer Sci; 2020 Oct; 111(10):3550-3563. PubMed ID: 32726486
[TBL] [Abstract][Full Text] [Related]
16. Hsa-miR-21-3p associates with breast cancer patient survival and targets genes in tumor suppressive pathways.
Amirfallah A; Knutsdottir H; Arason A; Hilmarsdottir B; Johannsson OT; Agnarsson BA; Barkardottir RB; Reynisdottir I
PLoS One; 2021; 16(11):e0260327. PubMed ID: 34797887
[TBL] [Abstract][Full Text] [Related]
17. Identification of a six-microRNA signature as a potential diagnostic biomarker in breast cancer tissues.
Mahmoudian M; Razmara E; Mahmud Hussen B; Simiyari M; Lotfizadeh N; Motaghed H; Khazraei Monfared A; Montazeri M; Babashah S
J Clin Lab Anal; 2021 Nov; 35(11):e24010. PubMed ID: 34528314
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA profiling in serum: Potential signatures for breast cancer diagnosis.
Zou X; Xia T; Li M; Wang T; Liu P; Zhou X; Huang Z; Zhu W
Cancer Biomark; 2021; 30(1):41-53. PubMed ID: 32894240
[TBL] [Abstract][Full Text] [Related]
19. Meta-microRNA Biomarker Signatures to Classify Breast Cancer Subtypes.
Oztemur Islakoglu Y; Noyan S; Aydos A; Gur Dedeoglu B
OMICS; 2018 Nov; 22(11):709-716. PubMed ID: 30388053
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA H19 acts as a miR-340-3p sponge to promote epithelial-mesenchymal transition by regulating YWHAZ expression in paclitaxel-resistant breast cancer cells.
Yan L; Yang S; Yue CX; Wei XY; Peng W; Dong ZY; Xu HN; Chen SL; Wang WR; Chen CJ; Yang QL
Environ Toxicol; 2020 Sep; 35(9):1015-1028. PubMed ID: 32420678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
